01-02-2014 | Head and Neck
Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy
Published in: European Archives of Oto-Rhino-Laryngology | Issue 2/2014
Login to get access